Debt-to-equity of DMK PHARMACEUTICALS Corp from 30 Jun 2017 to 30 Sep 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
DMK PHARMACEUTICALS Corp quarterly Debt-to-equity in % history and change rate from 30 Jun 2017 to 30 Sep 2023.
  • DMK PHARMACEUTICALS Corp Debt-to-equity for the quarter ending 30 Sep 2023 was -219%, a 341% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

DMK PHARMACEUTICALS Corp Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2023 -219% -309% -341% 30 Sep 2023
Q2 2023 -285% -343% -592% 30 Jun 2023
Q1 2023 -8298% -8343% -18750% 31 Mar 2023
Q4 2022 184% +144% +356% 31 Dec 2022
Q3 2022 91% +34% +60% 30 Sep 2022
Q2 2022 58% -15% -20% 30 Jun 2022
Q1 2022 44% -50% -53% 31 Mar 2022
Q4 2021 40% -68% -63% 31 Dec 2021
Q3 2021 57% -12% -18% 30 Sep 2021
Q2 2021 73% +24% +49% 30 Jun 2021
Q1 2021 94% +55% +139% 31 Mar 2021
Q4 2020 108% +72% +198% 31 Dec 2020
Q3 2020 69% +37% +119% 30 Sep 2020
Q2 2020 49% +21% +74% 30 Jun 2020
Q1 2020 39% +9.5% +32% 31 Mar 2020
Q4 2019 36% +6.8% +23% 31 Dec 2019
Q3 2019 31% +0.29% +0.93% 30 Sep 2019
Q2 2019 28% -3.9% -12% 30 Jun 2019
Q1 2019 30% +2.1% +7.7% 31 Mar 2019
Q4 2018 30% -2.5% -7.8% 31 Dec 2018
Q3 2018 31% -5.2% -14% 30 Sep 2018
Q2 2018 32% -13% -29% 30 Jun 2018
Q1 2018 28% 31 Mar 2018
Q4 2017 32% 31 Dec 2017
Q3 2017 36% 30 Sep 2017
Q2 2017 45% 30 Jun 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.